As the prevalence of diabetes mellitus increases, so too does the number of available treatment modalities. Many diabetic therapies available in human medicine or on the horizon could hold promise in the management of small animal diabetes. However, it is important to consider how species differences in pathophysiology, management practices and goals, and lifestyle may affect the translation of such treatment modalities for veterinary use. This review article aimed to familiarize veterinarians with the more promising novel diabetic therapies and explore their possible applications in the treatment of canine and feline diabetes mellitus.
Keywords: Beta cell replacement therapy; GLP-1 analogs; Insulin infusion pump; SGLT-2 inhibitors; Smart insulin; Ultra-long-acting insulin analogs.
Copyright © 2023 Elsevier Inc. All rights reserved.